PharmTech Europe News

FUJIFILM Diosynth Biotechnologies Completes New Viral Vector Gene Therapy Manufacturing Facility in UK

September 21, 2023

FUJIFILM Diosynth Biotechnologies has finished its new viral vector gene therapy manufacturing facility in Darlington, United Kingdom.

EC Approves Fixed-Dose Oral Combination Treatment for AML

September 20, 2023

Otsuka Pharmaceutical Europe and Astex Pharmaceuticals have announced the approval of INAQOVI by the European Commission.

Pharma Award Finalists for CPHI Barcelona Have Been Announced

September 19, 2023

The finalists for this year’s CPHI Barcelona Pharma Awards span 12 categories with awards ranging from accelerating innovations through to improved sustainability and best start-up initiative.

EMA Prepares for Regulation on Health Technology Assessment

September 19, 2023

The agency’s work with EUnetHTA 21 helped it to prepare the EU for implementation of the regulation.

EMA Grants Priority Medicine Status to Cellectar’s Waldenstrom Macroglobulinemia Treatment

September 19, 2023

Iopofosine provides targeted delivery of idodine-131 directly to cancer cells.

EMA Committee Issues Positive Opinion on Sandoz’ Biosimilar Trastuzumab

September 18, 2023

The EMA’s Committee for Medicinal Products for Human Use has given a positive opinion on Sandoz’ biosimilar trastuzumab for breast and gastric cancer.

PRAC Recommends New Measures to Avoid Topiramate Exposure in Pregnancy

September 11, 2023

Topiramate can cause serious birth defects if exposed to children in the womb.

Harnessing the Power of Oncolytic Viruses

September 03, 2023

Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.

Booster Shot for Pharma

September 02, 2023

European vaccine manufacturing is being boosted with high level investments.

Pfizer and BioNTech Get Positive Opinion in Europe for Omicron XBB.1.5-adapted COVID-19 Vaccine

August 31, 2023

The updated vaccine will be ready to ship following a positive European Commission review.